You searched for Adrian Towse - Page 5 of 17 - OHE

We found for

Comparative and Relative Effectiveness: A Challenge For Health Systems, Regulators, or Pharmaceutical Companies?

Read more

The Expanding Value Footprint of Oncology Treatments

Read more

What is the Role of HTA for Biosimilars?

Read more

Critique of CHE Research Paper 81: Methods for the Estimation of the NICE Cost Effectiveness Threshold

Read more

Exploring the link between health and wealth in decision making

Read more

The R&D Cost of a New Medicine

Read more

Can and Should Value Based Pricing Be Applied to Molecular Diagnostics?

Read more

The Use of Pay-for-Performance for Drugs: Can It Improve Incentives for Innovation?

Read more

Operationalising Value Based Pricing of Medicines: A Taxonomy of Approaches

Read more

Incentives for R&D for New Antimicrobial Drugs

Read more

New Drugs to Tackle Antimicrobial Resistance: Analysis of EU Policy Options

Read more

Pharmaceutical Pricing in Europe: Is Differential Pricing a Win-Win Solution?

Read more

The Evolution of HTA in Emerging Markets Health Care Systems: Analysis to Support a Policy Response

Read more

Biosimilars: How Much Entry and Price Competition Will Result?

Read more

Using QALYs in Cancer: Review of the Methodological Limitations

Read more

Researching the Relative Efficacy and Relative Effectiveness of Medicines across Europe

Read more

01
02
03
04
05
06
07